Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.
The American Cancer Society Cancer Action Network (ACS CAN) has been provided nearly one million dollars in support from Amgen for a pilot program to test a trial eligibility screening intervention intended to increase and diversify patient enrollment in cancer clinical trials.
head of the president’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is offering numerous policy suggestions for ways in which the administration and Congress can achieve the president’s ambitious Cancer Moonshot goal.
Nearly 100 cancer organizations representing patients, providers and researchers sent a letter to the president and congressional leadership in support of funding the Cancer Moonshot initiative
Advocates are pushing Congress to increase cancer research funding at that National Institutes of Health (NIH), National Cancer Institute (NCI) and to fund the president’s proposal to create the Advanced Research Project on Health (ARPA-H) as part of the FY 2022 federal budget.
The American Cancer Society Cancer Action Network is celebrating the 50th anniversary of President Richard Nixon’s signing of the National Cancer Act into law. The law, which took effect December 23, 1971, transformed the nation’s approach to preventing, detecting, and treating the disease.
Dr. Karen E. Knudsen, CEO of the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) issued the following statement in response to the announced retirement of the National Institutes of Health Director, Dr. Francis Collins.
Nearly 700 cancer advocates, including patients, survivors and their loved ones, from all 50 states and territories and nearly every congressional district will dial into calls and log onto virtual meetings this week to ask members of Congress to make the fight against cancer a national priority
This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever.
Washington, D.C.— The DIVERSE Trials Act, introduced in both the House and Senate would increase diversity in clinical trials and make it easier for all cancer patients to participate in clinical trials. The bipartisan bicameral legislation, sponsored by Sens.